Citi Raises Bristol-Myers (BMY) Target as Sector Outlook Improves into 2026

Bristol-Myers Squibb Company (NYSE:BMY) is included among the 14 High Yield Dividend Stocks with Sustainable Payouts. Citi Raises Bristol-Myers (BMY) Target as Sector Outlook Improves into 2026 On January 27, Citi analyst Geoff Meacham raised his price objective on Bristol-Myers Squibb Company (NYSE:BMY) to $60 from $53. The analyst maintained a Neutral rating and mentioned that the change came as part of a broader Q4 preview for the biopharma sector. Citi adjusted targets across the group, with Meacham ...